Home
About
Overview
Sharing Data
ORCID
Help
History (1)
The distinct metabolic phenotype of lung squamous cell carcinoma defines selective vulnerability to glycolytic inhibition.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The distinct metabolic phenotype of lung squamous cell carcinoma defines selective vulnerability to glycolytic inhibition.
The distinct metabolic phenotype of lung squamous cell carcinoma defines selective vulnerability to glycolytic inhibition. Nat Commun. 2017 05 26; 8:15503.
View in:
PubMed
subject areas
Adenocarcinoma
Adult
Aged
Aged, 80 and over
Animals
Carcinoma, Non-Small-Cell Lung
Carcinoma, Squamous Cell
Cell Line, Tumor
Cohort Studies
Deoxyglucose
Female
Fluorodeoxyglucose F18
Gene Expression Profiling
Gene Expression Regulation, Neoplastic
Glucose
Glucose Transporter Type 1
Glycolysis
Humans
Hydroxybenzoates
Lung
Lung Neoplasms
Male
Mice
Mice, Nude
Middle Aged
Phenotype
Positron-Emission Tomography
Prognosis
Survival Analysis
Up-Regulation
Xenograft Model Antitumor Assays
authors with profiles
Pankaj Kumar Singh